To the Moon
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Booooooooom MONSTER buys rolling in at .0004 Bid at .0003 got really thick, here goes $TXTM
Thats why its good to stick a toe in the water. Buy in small lots to get your starter, then once we see the reversal go all in. Dollar cost averaging at its finest!
Shares traded as low as .20 today, still sniffing out its bottom. When this one does rebound its going to go up hard!
Zzzzzzzz
$MIHI One of the few companies thats done a R/S and has gone up after! Great share structure here, will be interesting to see how this develops in the days and weeks ahead!
$DIBZ is a nobrainer from .25-.50 entry point IMO
52 week high $4.00 lots of upside potential here
$DIBZ has a super tight float can easily bounce back to recent highs
Came down on super light volume
$DIBZ .24x .32 today spread starting to tighten
I just called the TA and they told me that the company has to approve of that info being sent out. They requested I email them and they will forward to the company for them to sign off on it. So I emailed them, lets see if they will be transparent and show their hand....
Wrong info look at company name and TA that info was for TSTS not TXTM
Wrong info thats for TSTS not TXTM look at the Company name and TA both wrong for TXTM but right for TSTS...
I wouldnt jump to conclusions that is the wrong T/A info posted... Atleast according to OTCMarkets
How come the T/A is listed as ClearTrust, LLC under their profile info on OTCMarkets? http://www.otcmarkets.com/stock/TXTM/profile
TXTM Security Details
Share Structure
Market Value1 $778,676 a/o Jan 10, 2017
Authorized Shares Unlimited a/o Dec 14, 2016
Outstanding Shares 1,946,690,324 a/o Dec 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 1,716,220,028 a/o Dec 14, 2016
Par Value Not Available
Transfer Agent(s)
ClearTrust, LLC
Shareholders
Yea thats incorrectly worded because the OS includes the free trading public float. Plandai doesn't own or have control off that. Those shares are in retail traders hands aka the shareholders. To the best of my knowledge they are getting the control block which will give them the majority interest in the stock, hense control. I want to see it released in a filing to give more clarification on the exact parameters. I have taken notice to the updated website which looks nice.
They didn't buy anything, its a share agreement. Waiting to see the filings that shows how many shares were exchanged etc...
Nothing can be added or deposited when the stock has a yield sign. Just some food for thought $TXTM, brokers will not clear shares in this till they are current. Find me a broker that does and prove me wrong!
Yup out with the Old $TXTM (David Lewis) in with the New Sub of $PLPL and its management
Nice welcome aboard, for all the newcomers please put in a symbol request for $TXTM to Stockcharts.com http://stockcharts.com/support/symbolrequest.html
Also Mark the $TXTM board
Thanks,
Sumo
Agreed 6 is key breakout point then .0009! Would love to see $TXTM close at 6 or better today. Hardly any shares were available at .0003. Higher lows and higher highs confirms an uptrend. Dang flippers need to stop reloading the 4s and just wait for higher levels. It so wants to breakout!
Flippers who don't care about mid-long term gains. Short sighted traders who just want a tick or two!
He's like the boy who cried Wolf, not even worth listening to. $TXTM Real deal merger with $PLPL(.04)
80million on bid at .0003 on TXTM, over 100million in trading volume in the first half hour! Momo is back for $TXTM, news with $PLPL is the catalyst for new highs.
YES Great seeing you here MRK, lets goo $TXTM
Isn't it amazing how quick the lay of the landscape can change on L2. $TXTM gearing up for MONSTER MOVE!!!
BAM Some more size just took out the offers 5s coming go $TXTM
L2 Shifting, Bid at .0003 continues to grow. Offers at .0004 should lift here soon. CDEL is the only large seller showing 26million the next large seller is ETRF showing 7.7 millly all the other MM's have much smaller blocks on the ask. Once we break .0005 it will be off to the races again! These .0004 flippers are probably folks who bought at .0002 or .0003 and happy with 35-50%. Not me I am holding for higher levels...
$TXTM 15milly slap at .0004, sellers stand down, let the stock breath!!
3 bid building, time to see the 4's plowed down! Go $TXTM
Boom boom time!!! Go $TXTM
OTC Markets
HomeMarketplacesMarket ActivityNewsServicesResearchLearn
Company Directory|Stock Screener
OTC Market Totals
8,271
Securities
$652.3M
Dollar Volume
6.7B
Share Volume
109,393
Trades
QuoteChartsCompany ProfileNewsFinancialsFilings and DisclosureShort SalesInsider DisclosureResearch ReportsVideos and Presentations
TXTM
ProText Mobility, Inc.
?
Common StockSEC Reporting - Delinquent
Pink Limited Information
0.00040.00 (0.00%) at Jan 9, 2017
Real-Time Best Bid & Ask
0.0002 / 0.0004 (1 x 1)Why is size 1?
OTC Disclosure & News Service
No news items have been posted for TXTM
< Back
Plandai Biotechnology Announces Share Exchange Between Protext Mobility and Plandai's South Africa Subsidiary
Plandai South Africa Will Operate Independent From Plandai Parent and Focus on Pharmaceutical Application Research
BOCA RATON, FL -- (Marketwired) -- 01/10/17 -- Plandaí Biotechnology, Inc. (OTC PINK: PLPL) ("Plandaí" or "the Company"), producer of the highly bioavailable Phytofare® catechin complex, today announced that it has completed a share exchange between Plandaí Biotechnology South Africa (PTY) LTD "Plandaí SA," and Protext Mobility, Inc. (OTC PINK: TXTM) "Protext", a Delaware company. Under the terms of the Exchange Agreement, Plandaí became the majority owner of Protext with Plandaí SA becoming the successor issuer to Protect for reporting and accounting purposes. It is anticipated that the prior operations and assets of Protext will be liquidated in the coming weeks, leaving Plandaí SA as the surviving operating entity.
Plandaí SA was established in 2014 by Plandaí Biotechnology, Inc. to provide a platform for expanding the research of Plandaí's proprietary Phytofare® extracts into pharmaceutical application and then obtaining product claims. Phytofare® has been clinically proven in human studies to provide ten times greater bioavailability, which is the ability of the body to absorb the nutrients, over generic plant extracts. The first product brought to market, Phytofare® catechin complex, is derived from green tea and contains all eight catechins in a highly absorbable biocompatible structure. Where the parent company, Plandaí Biotechnology, focuses on selling Phytofare® as an ingredient to manufacturers in the nutraceutical industry, Plandaí SA will target the pharmaceutical market with a finished product.
Plandaí SA has the exclusive license and rights to develop, manufacture, and sell all current and future Phytofare® extracts for the pharmaceutical market worldwide. The first targeted product will focus on treating diabetes by regulating blood sugar levels with an expectation of being market ready by the latter half of 2017.
Roger Baylis-Duffield, Chief Executive Officer of Plandaí, commented, "This strategic moves allows us to separate the research component of our business into a separate, self-funding entity, freeing up Plandaí to focus on Phytofare® manufacture and sales. Plandaí SA will operate with distinct management concentrating on pharmaceutical applications and obtaining drug and structure-function claims. Where Plandaí produces and sells an ingredient to the nutraceutical industry, Plandaí SA will produce a finished product targeting a specific application, such as managing glucose levels in diabetics."
About Plandaí Biotechnology, Inc. Plandaí Biotechnology, Inc (OTC PINK: PLPL). and its subsidiaries develop highly bioavailable extracts. It controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include cosmeceutical, wellness, anti-aging, pharmaceutical and animal husbandry.
For more information, please visit http://www.plandaibiotech.com.
Safe Harbor Statement This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.
CONTACT INFORMATION
Hannah Merrill
(435)881-3611
info@plandaibiotech.com
Source: Plandai Biotechnology, Inc.
< Back
Our Markets
???
Market Info
Contact UsAdvertisingMarket Hours/Holidays
Corporate Info
About UsInvestor RelationsPress CenterCareers
Sign up for the Newsletter
?
View Previous Newsletters
Follow Us: ? ? ? ?
© 2016 OTC Markets Group Inc.Terms of ServiceLinking TermsTrademarksPrivacy StatementRisk WarningSite MapGive FeedbackSupported Browsers? Jump to Top
OTC Link® ATS provided by OTC Link LLC, member FINRA / SIPC, a wholly owned subsidiary of OTC Markets Group Inc.
OTCQX, OTCQB and Pink markets designated by OTC Markets Group.
I've invested into a lot of beer drinking over the years to build it up! LOL It doesn't let me and others down often... Fingers crossed its right on!
I have a gut feeling that it should be any day now! We are super close, I can feel it... My gut usually never lets me down...
Tick Tock this $TXTM time bomb is gearing up for a Booooom
Just need a couple of big slaps at .0004 to get the Momo cranking again here. Excited to see $TXTM deliver on the completed acquisition news!
Selling at .0003 has evaporated $TXTM on the launch pad for a rebound here. Once people realize they can't get .0003 they are going to have to pay .0004 or better. Once the .0004 and .0005 clear this should lift easily to .001 or higher!
Hell Yea Baby $TXTM
$TXTM, lets crack .0004 to close out the week and set the stage for a BIG week next week!